Skip to main content
logo
Viva Biotech Holdings (VBIZF)
OTCMKTS · Delayed Price · Currency is USD
0.3434
+0.1526 (79.98%)
At close: Jan 26, 2026

Viva Biotech Holdings Revenue

Viva Biotech Holdings had revenue of 831.87M CNY in the half year ending June 30, 2025, a decrease of -27.17%. This brings the company's revenue in the last twelve months to 1.84B, down -7.94% year-over-year. In the year 2024, Viva Biotech Holdings had annual revenue of 1.99B, down -7.84%.

Revenue (ttm)
1.84B CNY
Revenue Growth
-7.94%
P/S Ratio
2.48
Revenue / Employee
880.91K CNY
Employees
2,085
Market Cap
637.07M USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241.99B-168.93M-7.84%
Dec 31, 20232.16B-224.05M-9.42%
Dec 31, 20222.38B275.55M13.10%
Dec 31, 20212.10B1.41B201.90%
Dec 31, 2020696.96M373.90M115.74%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BioStem Technologies292.21M
Vaxart148.20M
Silence Therapeutics25.83M
Nuo Therapeutics2.61M
Northwest Biotherapeutics937.00K
Arch Biopartners198.11K
Revenue Rankings

Viva Biotech Holdings News

More News